These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 8536780)
21. Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study. Malekzad F; Arbabi M; Mohtasham N; Toosi P; Jaberian M; Mohajer M; Mohammadi MR; Roodsari MR; Nasiri S J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):948-50. PubMed ID: 19453814 [TBL] [Abstract][Full Text] [Related]
22. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Chick J; Anton R; Checinski K; Croop R; Drummond DC; Farmer R; Labriola D; Marshall J; Moncrieff J; Morgan MY; Peters T; Ritson B Alcohol Alcohol; 2000; 35(6):587-93. PubMed ID: 11093966 [TBL] [Abstract][Full Text] [Related]
23. Naltrexone in the treatment of alcohol dependence. Krystal JH; Cramer JA; Krol WF; Kirk GF; Rosenheck RA; N Engl J Med; 2001 Dec; 345(24):1734-9. PubMed ID: 11742047 [TBL] [Abstract][Full Text] [Related]
24. Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Grant JE; Kim SW; Hollander E; Potenza MN Psychopharmacology (Berl); 2008 Nov; 200(4):521-7. PubMed ID: 18581096 [TBL] [Abstract][Full Text] [Related]
25. High-dose naltrexone and liver function safety. Marrazzi MA; Wroblewski JM; Kinzie J; Luby ED Am J Addict; 1997; 6(1):21-9. PubMed ID: 9097868 [TBL] [Abstract][Full Text] [Related]
26. [Limited role of naltrexone in the treatment of opiate addiction]. van Brussel GH Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1452-6. PubMed ID: 11503313 [TBL] [Abstract][Full Text] [Related]
27. The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone. Bisaga A; Sullivan MA; Glass A; Mishlen K; Pavlicova M; Haney M; Raby WN; Levin FR; Carpenter KM; Mariani JJ; Nunes EV Drug Alcohol Depend; 2015 Sep; 154():38-45. PubMed ID: 26187456 [TBL] [Abstract][Full Text] [Related]
28. Use of naltrexone in postmenopausal women with exaggerated insulin secretion: a pilot study. Cucinelli F; Soranna L; Perri C; Barini A; Cento RM; Mancuso S; Lanzone A Fertil Steril; 2004 Apr; 81(4):1047-54. PubMed ID: 15066462 [TBL] [Abstract][Full Text] [Related]
29. A pilot trial of injectable, extended-release naltrexone for the treatment of co-occurring cocaine and alcohol dependence. Pettinati HM; Kampman KM; Lynch KG; Dundon WD; Mahoney EM; Wierzbicki MR; O'Brien CP Am J Addict; 2014; 23(6):591-7. PubMed ID: 25251201 [TBL] [Abstract][Full Text] [Related]
30. Effect of sildenafil citrate on the male sexual experience assessed with the Sexual Experience Questionnaire: a multicenter, double-blind, placebo-controlled trial with open-label extension. Jones LA; Klimberg IW; McMurray JG; Padula R; Tseng LJ; Stecher VJ J Sex Med; 2008 Aug; 5(8):1955-64. PubMed ID: 18564150 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease. Conti CR; Pepine CJ; Sweeney M Am J Cardiol; 1999 Mar; 83(5A):29C-34C. PubMed ID: 10078540 [TBL] [Abstract][Full Text] [Related]
33. Long-term effects of naltrexone on self-injurious behavior. Sandman CA; Hetrick W; Taylor DV; Marion SD; Touchette P; Barron JL; Martinezzi V; Steinberg RM; Crinella FM Am J Ment Retard; 2000 Mar; 105(2):103-17. PubMed ID: 10755174 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction-A prospective, randomized, double-blind, placebo-controlled clinical trial. Kamenov Z; Fileva S; Kalinov K; Jannini EA Maturitas; 2017 May; 99():20-26. PubMed ID: 28364864 [TBL] [Abstract][Full Text] [Related]
35. Asian sildenafil efficacy and safety study (ASSESS-1): a double-blind, placebo-controlled, flexible-dose study of oral sildenafil in Malaysian, Singaporean, and Filipino men with erectile dysfunction. The Assess-1 Study Group. Tan HM; Moh CL; Mendoza JB; Gana T; Albano GJ; de la Cruz R; Chye PL; Sam CC Urology; 2000 Oct; 56(4):635-40. PubMed ID: 11018621 [TBL] [Abstract][Full Text] [Related]
36. Effects of incentives for naltrexone adherence on opiate abstinence in heroin-dependent adults. Jarvis BP; Holtyn AF; DeFulio A; Dunn KE; Everly JJ; Leoutsakos JS; Umbricht A; Fingerhood M; Bigelow GE; Silverman K Addiction; 2017 May; 112(5):830-837. PubMed ID: 27936293 [TBL] [Abstract][Full Text] [Related]
37. Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study. Mann K; Lemenager T; Hoffmann S; Reinhard I; Hermann D; Batra A; Berner M; Wodarz N; Heinz A; Smolka MN; Zimmermann US; Wellek S; Kiefer F; Anton RF; Addict Biol; 2013 Nov; 18(6):937-46. PubMed ID: 23231446 [TBL] [Abstract][Full Text] [Related]
38. Does adding low doses of oral naltrexone to morphine alter the subsequent opioid requirements and side effects in trauma patients? Farahmand S; Ahmadi O; Dehpour A; Khashayar P Am J Emerg Med; 2012 Jan; 30(1):75-8. PubMed ID: 21075578 [TBL] [Abstract][Full Text] [Related]
39. A pilot study to assess the impact of naltrexone implant on accidental opiate overdose in 'high-risk' adolescent heroin users. Hulse GK; Tait RJ Addict Biol; 2003 Sep; 8(3):337-42. PubMed ID: 13129836 [TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of oral tadalafil in the treatment of men in Canada with erectile dysfunction: a randomized, double-blind, parallel, placebo-controlled clinical trial. Carrier S; Brock GB; Pommerville PJ; Shin J; Anglin G; Whitaker S; Beasley CM J Sex Med; 2005 Sep; 2(5):685-98. PubMed ID: 16422827 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]